亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Indoco launches favipiravir 400 mg tablets

expresspharmaSeptember 28, 2020

Tag: favipiravir , Indoco , COVID-19 , FEVINDO

Indoco Remedies announced the launch of FEVINDO (favipiravir) 400 mg tablets in India. Fevindo – 400 is an antiviral drug, effective against the RNA-based influenza virus.

The drug has been approved by DCGI in the treatment of COVID-19.

Aditi Kare Panandikar, MD, Indoco Remedies commented, “With the launch of FEVINDO, we are taking the next step from prevention to the treatment of COVID-19.”

Fevindo – 400 will be made available at all government approved COVID care centres and selected medical practitioners across the country.

Previous:Happiness Biotech Announces $2.25 Million Private Placement In Support of Happy Buy

Next:Preventing counterfeiting with global identification standard

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service